Citable company snapshot
Quest Diagnostics's latest SEC-sourced 2026-03-31 period shows $2.90B in revenue and $252.00M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:RevenueFromContractWithCustomerExcludingAssessedTax | Mar 31, 2026 | $2.90B | $2.81B | +3.2% |
| xbrl:GrossProfit | Dec 31, 2020 | $1.27B | $1.21B | +5.2% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $399.00M | $386.00M | +3.4% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $252.00M | $245.00M | +2.9% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $278.00M | $465.00M | -40.2% |
| Free Cash Flow (computed) | Mar 31, 2026 | $164.00M | $307.00M | -46.6% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 22, 2026; accession 0001022079-26-000043.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
